Despite the growing use of safer nicotine being strongly associated with declining smoking rates, there is still systemic opposition to these products from institutions and NGOs - but why is this the case? In this episode Lindsey Stroud joins us to unpack the FDA's reluctance to approve new nicotine products, and the misinformation used to prop up the opposition to THR.
